CLINICAL RESULTS OF RIFAMPICIN TREATMENT

被引：0

|

作者：

VIRCHOW, C

FLEMMING, J

机构：

来源：

ANTIBIOTICA ET CHEMOTHERAPIA | 1970年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：471 / &

相关论文

共 50 条

[1] Clinical efficacy of rifampicin for treatment of canine pyoderma
Sentürk, S
Özel, E
Sen, A
ACTA VETERINARIA BRNO, 2005, 74 (01) : 117 - 122
[2] EXPERIMENTAL AND CLINICAL STUDIES ON RIFAMPICIN IN TREATMENT OF LEPROSY
REES, RJW
PEARSON, JMH
WATERS, MFR
BRITISH MEDICAL JOURNAL, 1970, 1 (5688): : 89 - &
[3] RESULTS OF CLINICAL STUDIES WITH CAPREOMYCIN, ETHAMBUTOL AND RIFAMPICIN IN HECKESHORN HOSPITAL, BERLIN
RADENBAV.KL
SCANDINAVIAN JOURNAL OF RESPIRATORY DISEASES, 1969, S : 43 - &
[4] RIFAMPICIN - A CLINICAL SURVEY
BERGAMINI, N
BACHINI, V
FERRARIO, A
INNOCENTI, G
FOWST, G
ARZNEIMITTEL-FORSCHUNG, 1970, 20 (10): : 1546 - +
[5] RESULTS OF A CONTROLLED CLINICAL-TRIAL OF THE EFFECT OF RIFAMPICIN ON LIPID-METABOLISM
OBERDISSE, E
KRAUSE, I
GOBEL, D
RADENBACH, KL
PRAXIS UND KLINIK DER PNEUMOLOGIE, 1981, 35 : 1059 - 1061
[6] CLINICAL PHARMACOKINETICS OF RIFAMPICIN
ACOCELLA, G
CLINICAL PHARMACOKINETICS, 1978, 3 (02) : 108 - 127
[7] Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients
Verbeeck, Roger K.
Singu, Bonifasius S.
Kibuule, Dan
CLINICAL PHARMACOKINETICS, 2019, 58 (12) : 1511 - 1515
[8] Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients
Roger K. Verbeeck
Bonifasius S. Singu
Dan Kibuule
Clinical Pharmacokinetics, 2019, 58 : 1511 - 1515
[9] Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment
Khadka, Prakash
Dummer, Jack
Hill, Philip C.
Das, Shyamal C.
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 548 (01) : 244 - 254
[10] RESULTS AND TOLERANCE OF PROLONGED RIFAMPICIN TREATMENT IN RECENT AND CHRONIC FORMS OF PULMONARY TUBERCULOSIS
NITTI, V
RESPIRATION, 1971, 28 : 57 - &

← 1 2 3 4 5 →